Sandoz Canada is a major Canadian supplier of off-patent medicines, with public materials highlighting leadership in generics, biosimilars, and injectable products. The company focuses on expanding access to medicines and operates across broad therapeutic categories with a large marketed portfolio. Its business model centers on established pharmaceuticals, biologic copies, and hospital-accessible medicines rather than early-stage discovery.